Cancer hospitals across the nation are marking up the price of cancer therapies for health insurers anywhere from double to nearly seven times the cost of acquiring them, a study published April 18 in JAMA Internal Medicine found.
Read the full post on Becker's Hospital Review - Healthcare News
